doxorubicin hydrochloride
Generic: doxorubicin hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
doxorubicin hydrochloride
Generic Name
doxorubicin hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
doxorubicin hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-883
Product ID
63323-883_89998b96-8ca7-4eb1-98a4-e533420d0e72
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA063277
Listing Expiration
2026-12-31
Marketing Start
2000-04-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323883
Hyphenated Format
63323-883
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
doxorubicin hydrochloride (source: ndc)
Generic Name
doxorubicin hydrochloride (source: ndc)
Application Number
ANDA063277 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-05) / 5 mL in 1 VIAL, SINGLE-DOSE
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-10) / 10 mL in 1 VIAL, SINGLE-DOSE
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-30) / 25 mL in 1 VIAL, SINGLE-DOSE
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "89998b96-8ca7-4eb1-98a4-e533420d0e72", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1191138", "1790097", "1790099", "1790100"], "spl_set_id": ["e0349f98-42fa-4003-b6d8-a1db1401b0ef"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-05) / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-883-05", "marketing_start_date": "20000414"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-10) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-883-10", "marketing_start_date": "20000414"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-30) / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-883-30", "marketing_start_date": "20000414"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "63323-883_89998b96-8ca7-4eb1-98a4-e533420d0e72", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "63323-883", "generic_name": "DOXORUBICIN HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA063277", "marketing_category": "ANDA", "marketing_start_date": "20000414", "listing_expiration_date": "20261231"}